ABVC Biopharma Inc (ABVC) stock news · $35.9M cap
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
This ABVC news page leads with what ABVC Biopharma Inc filed — not a scraped headline mill.
No cached 8-K sentence for ABVC yet. We will not pad this page with generic market recap.
Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.2M. Revenue was up 104.5% from 2024-09-30 to 2025-09-30. ABVC currently screens at market cap $35.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ABVC stock page; for the tape open the quote page.
ABVC stock news FAQ
What are ABVC's latest revenue and net income?
Latest cached ABVC Biopharma Inc (ABVC) revenue for Sep 30, 2025 was $796.0K. Net income was -$1.2M. Statements: https://lician.com/financials/abvc
How did ABVC revenue change from the prior cached period?
Cached ABVC Biopharma Inc (ABVC) revenue was up 104.5% from $389.3K (Sep 30, 2024) to $796.0K (Sep 30, 2025). Statements: https://lician.com/financials/abvc
What is ABVC's market cap?
ABVC Biopharma Inc (ABVC) market cap is $35.9M on the latest cached fundamentals snapshot.
What kind of company is ABVC?
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
Where is ABVC stock news listed?
Cached stock news for ABVC Biopharma Inc (ABVC) is listed at https://lician.com/news/abvc. Filings: https://lician.com/sec/abvc
Not investment advice.